Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
International Journal of Rheumatic Diseases|April 25, 2023
Iatrogenic Demodex folliculitis: A case reportNeha Deo, Nasro A Isaq, Margot S Peters, et al.Acta Dermato-Venereologica|January 8, 2008
Loss-of-function variants of the filaggrin gene are associated with atopic eczema and associated phenotypes in Swedish familiesElisabeth Ekelund, Agne Liedén, Jenny Link, et al.Plos One|March 11, 2014
Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosisJenny Link, Malin Lundkvist Ryner, Katharina Fink, et al.Journal of Neuroimmunology|August 4, 2010
Two HLA class I genes independently associated with multiple sclerosisJenny Link, Aslaug R Lorentzen, Ingrid Kockum, et al.Plos One|May 16, 2012
Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosisJenny Link, Ingrid Kockum, Aslaug R Lorentzen, et al.Journal of Neuroimmunology|July 12, 2011
No influence on disease progression of non-HLA susceptibility genes in MSWangko Lundström, Eva Greiner, Frida Lundmark, et al.Neurology. Genetics|September 22, 2016
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis riskBrooke Rhead, Maria Bäärnhielm, Milena Gianfrancesco, et al.Plos Pathogens|April 26, 2014
JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variantsEmilie Sundqvist, Dorothea Buck, Clemens Warnke, et al.Nature Genetics|November 11, 2008
Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosisYurii S Aulchenko, Ilse A Hoppenbrouwers, Sreeram V Ramagopalan, et al.BMC Medicine|November 4, 2020
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWASTill F M Andlauer, Jenny Link, Dorothea Martin, et al.Pageof 2